Inventor · disambiguated record
Shankar Venkatraman
Also filed as: VENKATRAMAN SHANKAR
33 granted patents·49 pending applications·150 citations·filing 2000–2025
96Inventor score
Files withIFM DUE INC25NOVARTIS AG18VITAE PHARMACEUTICALS INC10VITAE PHARMACEUTICALS LLC7AXYS PHARM INC5
Top patents by PatentIndex Score
82 records- 0195US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0295US6506733B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Jan 14, 2003·40 cites·18 claims
- 0391US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 0491US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 0591US8981112B2Inhibitors of β-secretaseBOEHRINGER INGELHEIM INT·Filed 2013·Granted Mar 17, 2015·14 cites·17 claims
- 0690US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 0788US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 0888US6476026B1Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2000·Granted Nov 5, 2002·27 cites·13 claims
- 0985US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 1085US8633212B2Inhibitors of beta-secretaseCACATIAN SALVACION·Filed 2010·Granted Jan 21, 2014·10 cites·22 claims
- 1184US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 1284US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 1384US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 1483US12152018B2Compounds and compositions for treating conditions associated with STING activityIFM DUE INC·Filed 2022·Granted Nov 26, 2024·1 cites·36 claims
- 1581US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 1681US6593327B2Compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2001·Granted Jul 15, 2003·11 cites·13 claims
- 1778US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 1877US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1975US9949975B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·1 cites·4 claims
- 2075US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2173US9290477B2Inhibitors of β-secretaseVITAE PHARMACEUTICALS INC·Filed 2013·Granted Mar 22, 2016·2 cites·18 claims
- 2273US6525036B2Compounds and compositions as protease inhibitorsMERCK & CO INC·Filed 2001·Granted Feb 25, 2003·8 cites·25 claims
- 2372US9018391B2Inhibitors of beta-secretaseBUKHTIYAROV YURI·Filed 2013·Granted Apr 28, 2015·2 cites·38 claims
- 2471US9526727B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·12 claims
- 2571US9045500B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jun 2, 2015·1 cites·10 claims
- 2670US11618749B2Compounds and compositions for treating conditions associated with STING activityIFM DUE INC·Filed 2019·Granted Apr 4, 2023·1 cites·12 claims
- 2770US10336717B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 2, 2019·1 cites·9 claims
- 2870US9212153B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·1 cites·23 claims
- 2970US2025136597A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2024·Application pending·0 cites
- 3067US8889703B2Inhibitors of beta-secretaseDILLARD LAWRENCE W·Filed 2011·Granted Nov 18, 2014·1 cites·12 claims
- 3165US12421223B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2019·Granted Sep 23, 2025·0 cites·1 claims
- 3265US2024083895A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2023·Application pending·0 cites
- 3362US2025084071A1Compounds and compositions for treating conditions associated with sting activityNOVARTIS PHARMA AG·Filed 2023·Application pending·0 cites
- 3460US12503436B2Compounds and compositions for treating conditions associated with STING activityNOVARTIS PHARMA AG·Filed 2022·Granted Dec 23, 2025·0 cites·86 claims
- 3560US2023079631A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2022·Application pending·0 cites
- 3659US2022024919A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 3758US2023250060A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2023·Application pending·0 cites
- 3858US2018344734A1Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3956US2024076285A1Compounds and compositions for treating conditions associated with sting activityVENKATRAMAN SHANKAR·Filed 2021·Application pending·0 cites
- 4055US8513234B2HIV integrase inhibitorsISAACS RICHARD C A·Filed 2009·Granted Aug 20, 2013·0 cites·21 claims
- 4154US2024101556A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 4254US2024083879A1Oxalamide compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 4354US2024308978A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2022·Application pending·0 cites
- 4454US2022387397A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4553US2003119788A1Novel compounds and compositions as protease inhibitorsAXYS PHARM INC·Filed 2002·Application pending·0 cites
- 4653US2024051970A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 4753US2021395241A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4852US2023271941A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 4952US2023250106A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
- 5052US2022024906A1Compounds and compositions for treating conditions associated with sting activityIFM DUE INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shankar Venkatraman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →